ClinVar Miner

Submissions for variant NC_000011.9:g.(?_108198469)_(108225601_?)dup

Minimum review status: Collection method:
Minimum conflict level:
ClinVar version:
Total submissions: 1
Download table as spreadsheet
Submitter RCV SCV Clinical significance Condition Last evaluated Review status Method Comment
Labcorp Genetics (formerly Invitae), Labcorp RCV000708135 SCV000837245 likely pathogenic Ataxia-telangiectasia syndrome 2020-05-27 criteria provided, single submitter clinical testing This variant disrupts the kinase domain of the ATM protein, which is required for DNA damage response (PMID: 24667671). While functional studies have not been performed to directly test the effect of this variant on ATM protein function, this suggests that disruption of this region of the protein is causative of disease. In summary, the currently available evidence indicates that the variant is pathogenic, but additional data are needed to prove that conclusively. Therefore, this variant has been classified as Likely Pathogenic. This variant has been observed in individual(s) with ataxia-telangiectasia (Invitae). It has also been observed to segregate with disease in related individuals. This variant results in a copy number gain of the genomic region encompassing exon(s) 48-61 of the ATM gene. While the exact position of this variant cannot be determined from the data, sub-genic copy number gains are generally in tandem (PMID: 25640679). This variant is predicted to be in-frame, and likely preserves the integrity of the reading frame.

The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. Neither the University of Utah nor the National Institutes of Health independently verfies the submitted information. If you have questions about the information contained on this website, please see a health care professional.